| Soft-tissue augmentation with hyaluronic acid and calcium hydroxyl apatite fillers. | |
| | |
MedLine Citation:
|
PMID: 21276160 Owner: NLM Status: In-Data-Review |
Abstract/OtherAbstract:
|
Soft-tissue augmentation with hyaluronic acid and calcium hydroxyl apatite are among the most widely used minimally invasive cosmetic treatments for the correction of contour deficiencies and wrinkles of the face without the risk, recovery time, and expense of a major surgery. Training and experience in the art and science of fillers is essential for the successful creation of a more youthful and natural appearance. An understanding of the different products, the injection techniques, the indications, and the potential complications of each filler are paramount to success. |
| | |
Authors:
|
Kelley Pagliai Redbord; Mariano Busso; C William Hanke |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: Dermatologic therapy Volume: 24 ISSN: 1529-8019 ISO Abbreviation: Dermatol Ther Publication Date: 2011 Jan |
Date Detail:
|
Created Date: 2011-01-31 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 9700070 Medline TA: Dermatol Ther Country: Denmark |
Other Details:
|
Languages: eng Pagination: 71-81 Citation Subset: IM |
Copyright Information:
|
© 2011 Wiley Periodicals, Inc. |
Affiliation:
|
Private Practice, Washington DC Private Practice, Coconut Grove, Senior Attending of Dermatology at Mercy Hospital in Miami, Voluntary Assistant Clinical Professor of Dermatology at the University of Miami, Florida, and Private Practice, Carmel, Indiana, Clinical Professor Indiana University, Vice-Chairman, Department of Dermatology, St. Vincent Hospital, Indianapolis, Indiana. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Ablative fractional CO(2) resurfacing for photoaging of the hands: pilot study of 10 patients.
Next Document: MAL-PDT for difficult to treat nonmelanoma skin cancer.